Advertisement
Screener

Vivos Therapeutics, Inc. (VVOS) Operating Loss Carryforwards

2.8 / 5 stars · 68/120 Roast Me

Vivos Therapeutics, Inc. Operating Loss Carryforwards

Vivos Therapeutics, Inc. (VVOS) had Operating Loss Carryforwards of $104.60 million as of 2025-12-31, per its 10-K filed 2026-04-15.

Financial Statements › Notes › Income Taxes

us-gaap:OperatingLossCarryforwards · last filed 2026-04-15

  • 2025-12-31: Operating Loss Carryforwards $104.60M.
  • 2024-12-31: Operating Loss Carryforwards $83.80M.
  • 2023-12-31: Operating Loss Carryforwards $72.40M.
  • 2022-12-31: Operating Loss Carryforwards $58.20M.
Period endOperating Loss Carryforwards
2025-12-31$104.60M
10-K · filed 2026-04-15
2024-12-31$83.80M
10-K · filed 2025-03-31
2023-12-31$72.40M
10-K/A · filed 2024-07-30
2022-12-31$58.20M
10-K · filed 2023-03-30
2021-12-31$38.40M
10-K · filed 2022-03-31
2020-12-31$22.38M
10-K · filed 2021-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Profusa, Inc. (PFSA)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B